Deferoxamine Injection bulk supplier for pharma manufacturers

Deferoxamine Injection 500 mg/mL Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 500 mg/mL

Reference Brands: Desferal(US)

Deferoxamine binds to excess iron, forming a stable complex that is excreted in urine and feces. It effectively treats iron overload from transfusions and iron poisoning, preventing organ damage. Benefits include rapid reduction of iron levels, protection against toxicity, and improved patient outcomes in iron accumulation conditions.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Deferoxamine injection, marketed as Desferal, is approved in the US by the FDA and in the EU via EMA for treating iron overload and poisoning. Regulatory approval requires a detailed dossier including clinical safety, efficacy, manufacturing, and pharmacovigilance data. In the US, submission to the FDA involves comprehensive review, while in the EU, EMA guidelines ensure quality and safety standards are met. For expert guidance on dossier development, regulatory pathways, and successful market access, visit PharmaTradz. Ensuring compliance with regional regulations is essential for the safe and effective use of deferoxamine injection worldwide, supporting patients with iron overload conditions.

Deferoxamine Injection — third party manufacturing & bulk supply

Deferoxamine Injection 500 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Deferoxamine Injection is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Deferoxamine Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Deferoxamine Injection →

Back to Listing

Frequently Asked Questions

Deferoxamine Injection is listed as Injection in 500 mg/mL. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Deferoxamine Injection is referenced against Desferal(US). Reference brands are shown for identification only and remain the property of their respective trademark owners.